Corona

If there was one coronavirus stock you wanted to back in 2020, it was Novavax (NVAX). The small...

Inovio Pharmaceuticals (INO) has been playing catch up in the Covid-19 vaccine race for a while now. One...

Moderna’s (MRNA) opportunity to halt the spread of Covid-19 made the biotech company one of 2020’s star performers....

Ocugen (OCGN) has been a 2021 success story, as the eye disease specialist has decided to moonlight in...

The developments are coming in thick and fast at Sorrento Therapeutics (SRNE). Recent times have seen a flurry...

As the saying goes, when life gives you lemons, make lemonade. Or as Ocugen (OCGN) has adapted the...

Several coronavirus stocks were on the move this week in reaction to the CDC (Centers for Disease Control...

By now you’ve heard the news. On Tuesday, April 13, the U.S. Centers for Disease Control and Food...

Despite year-to-date gains of 61%, shares of Novavax (NVAX) have retreated by 44% since the yearly highs of...

Moderna (MRNA) stock currently sits 30% below the yearly highs reached in early February. Jefferies analyst Michael Yee...

Friday was not a fun day to be invested in Co-Diagnostics (CODX). Shares of the Coronavirus test maker...

Once a specialist in oncology drugs and pain management, last year, Sorrento Therapeutics (SRNE) refocused its business on...

The stock market has been pulled aggressively in both directions in 2021, but the moves are relatively tame...

Ocugen (OCGN) is a latecomer to the coronavirus stock party. But in true latecomer fashion, it has made...

The available vaccines’ questionable effectiveness against mutant strains and the logistic challenges of worldwide distribution, suggest the battle...

Despite the reduction in global Covid-19 cases, and the anticipated gradual return to normalcy, the fear of mutant...

B. Riley analyst Mayank Mamtani has long banged the drum for Novavax (NVAX). The latest developments surrounding the...

Shares of vaccine researcher Inovio Pharmaceuticals (INO) are currently trading around the $15 level, and one analyst thinks...

What does it take to move a stock price from $0.29 to $15.81 — an increase of 5,350%...

The new coronavirus mutant strains are playing havoc with the already approved Covid-19 vaccines. The latest data shows...

Novavax (NVAX) was the coronavirus stock to hold last year, as the company punched far above its weight...

It’s official, a new Covid-19 vaccine candidate has entered the fray. On Tuesday, Ocugen (OCGN) announced it had...

Over the past week, investors optimistically pushed Vaxart’s (VXRT) share price up by over 100%. High short-interest and...

In the race to bring a coronavirus vaccine to market, Novavax (NVAX) looked like a loser — lagging...

Coronavirus stocks played a massive part in the stock market’s 2020 narrative. However, in 2021, so far, Moderna...

Some companies favor a “do one job and do it well” approach. However, that is not the Sorrento...

2020 introduced the term “coronavirus stocks.” These are the companies working on solutions to fend off the Covid-19...

Think coronavirus stocks are so 2020? Think again. Shares of Gritstone Oncology (GRTS) took off by a whooping...

Over the past 12 months, Moderna’s (MRNA) share price has increased by a spectacular 517%. Of course, the...

The major U.S. equity-indexes are hovering around all-time highs, and a question that frequently pops up these days,...

From a company barely known outside industry circles a year ago, Moderna (MRNA) has now become a household...

Coronavirus-focused stocks have been prone to surge majestically after the announcement of positive news. Last Friday, Applied DNA...

Inovio Pharmaceuticals’ (INO) 2020 was a tale of two contrasting halves. Shares skyrocketed during the first 6 months...

Arcturus Therapeutics (ARCT) investors felt the impact of a thunderous thud on Tuesday, following the share price’s collapse....

Returns wise, Novavax (NVAX) has undoubtedly been the most successful coronavirus stock of them all, with 2020 gains...

Last week, Moderna’s (MRNA) Covid-19 vaccine candidate mRNA-1273 became the second approved vaccine in the U.S. after it...

Hot on the heels of the FDA granting EUA (emergency use authorization) for Pfizer/BioNTech’s Covid-19 vaccine BNT162b2, last...

Last week, Moderna (MRNA) kicked off its TeenCOVE Study, dosing the first participants in the Phase 2/3 trial...

Covid-19 has been responsible for a complete shift in how society operates. On a lighter note, it has...

Moderna (MRNA) stock has been one of 2020’s star performers, up 695%, and judging by its real-world results,...

2020 has been some journey for Inovio Pharmaceuticals (INO). For this formerly little-known biotech, the narrative has swung...

Roche has partnered with Moderna Inc. to use its anti-SARS-CoV-2 S antibody test in mRNA-1273 vaccine research trials....

Pfizer Inc. and BioNTech’s mRNA vaccine candidate, BNT162b2, against COVID-19, was found to be safe and effective, according...

Eli Lilly & Co. and insurer UnitedHealth Group have teamed up to conduct a pragmatic study of the...

Shares of Moderna surged 10% on Thursday after it revealed subjects in the Phase 1 study led by...

Eli Lilly has struck an $812.5 million agreement with the US government to supply an additional 650,000 vials of...

Pfizer Inc. and its German partner BioNTech will start to supply the UK with their mRNA vaccine from...

Pfizer Inc. and its German partner BioNTech have filed a formal application to the European Medicines Agency (EMA)...

Shares of Novavax sank more than 9% in Monday’s pre-market session as the drugmaker further delayed the start...

Moderna announced that it will file for US and European emergency use of its COVID-19 vaccine candidate on...